Healthcare Triangle, Inc.
Healthcare Triangle, Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related Party | - | - | - | - | - | - | 0 | -0 | 0 | 0 | 0 | 1 | |||||
Finite Lived Intangible Assets Net | - | - | 3 | - | - | - | - | - | - | 4 | 1 | 8 | |||||
Series C Preferred Stock | - | 18 | - | - | - | - | - | - | - | - | - | - | |||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 2 | 4 | 8 | 2 | 3 | 7 | 0 | 0 | 0 | 0 | 1 | 0 | |||||
Accounts Receivable Net Current | 6 | 8 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 4 | 0 | |||||
Other Receivables Net Current | - | - | - | 4 | 3 | - | - | - | 0 | - | - | - | |||||
Other Assets Current | 2 | 2 | 3 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | |||||
Assets Current | 10 | 19 | 13 | 8 | 9 | 10 | 1 | 2 | 2 | 3 | 6 | 5 | |||||
Other Receivable After Allowance For Credit Loss N… | - | - | - | - | - | 2 | - | - | - | - | 0 | - | |||||
Property Plant And Equipment Net | 1 | 1 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | - | 3 | 3 | - | 1 | - | |||||
Intangible Assets Net Including Goodwill | - | - | - | 6 | 6 | - | - | - | - | - | - | - | |||||
Other Intangible Assets Net | 55 | 55 | 3 | - | - | - | - | - | - | - | - | - | |||||
Other Receivables | - | - | 4 | - | - | - | 0 | - | - | - | - | - | |||||
Goodwill | 3 | 3 | 3 | - | - | - | - | - | - | - | - | 1 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | - | - | - | - | - | - | - | - | - | - | |||||
Other Assets Noncurrent | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Deferred Income Tax Assets Net | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Assets | 74 | 80 | 23 | 14 | 15 | 12 | 2 | 5 | 6 | 7 | 7 | 14 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Noncurrent | |||||||||||||||||
Asset Acquisition Contingent Consideration Liabili… | - | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Liabilities Current | |||||||||||||||||
Preferred Stock Value | - | - | - | - | - | 7 | 7 | - | - | - | - | - | |||||
Accounts Payable Current | 1 | 3 | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 1 | |||||
Derivative Liabilities Current | - | - | - | - | - | - | - | - | - | 1 | - | - | |||||
Warrants And Rights Outstanding | - | - | - | - | - | - | - | 1 | 1 | - | 1 | - | |||||
Short Term Borrowings | 9 | 9 | 11 | 2 | 0 | 1 | 3 | 1 | 2 | 2 | 4 | 3 | |||||
Operating Lease Liability Current | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Other Liabilities Current | 5 | 8 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | |||||
Asset Acquisition Contingent Consideration Liabili… | - | - | - | - | - | - | 1 | - | - | - | - | - | |||||
Liabilities Current | 16 | 21 | 13 | 4 | 3 | 3 | 7 | 6 | 6 | 6 | 8 | 7 | |||||
Long Term Liabilities | |||||||||||||||||
Long Term Notes Payable | 3 | 1 | - | - | - | - | - | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 1 | 1 | - | - | - | - | - | - | - | - | - | - | |||||
Asset Acquisition Contingent Consideration Liabili… | 5 | 5 | - | 1 | 1 | - | 1 | 1 | 1 | 1 | 1 | - | |||||
Convertible Long Term Notes Payable | - | - | - | - | - | - | - | - | - | 1 | 0 | - | |||||
Other Liabilities Noncurrent | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Liabilities | 25 | 27 | - | 5 | 4 | 3 | 7 | 7 | 7 | 7 | 8 | 8 | |||||
Stockholders Equity | |||||||||||||||||
Allowance For Doubtful Accounts Receivable Current | - | - | - | - | 0 | - | - | - | - | - | - | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | - | - | - | - | 0 | 0 | 0 | |||||
Minority Interest | -0 | -0 | -0 | -0 | - | - | - | - | - | - | - | - | |||||
Additional Paid In Capital | 65 | 77 | 46 | 37 | 39 | 36 | 21 | 28 | 28 | 26 | 26 | 26 | |||||
Retained Earnings Accumulated Deficit | -53 | -49 | -43 | -39 | -37 | -35 | -34 | -30 | -28 | -27 | -28 | -20 | |||||
Series B Convertible Preferred Stock | - | - | - | - | - | - | 2 | - | - | - | - | - | |||||
Stockholders Equity | 49 | 53 | 10 | 9 | 10 | 9 | -5 | -2 | -1 | -2 | -1 | 6 | |||||
Liabilities And Stockholders Equity | 74 | 80 | 23 | 14 | 15 | 12 | 2 | 5 | 6 | 7 | 7 | 14 | |||||
Series A Preferred Stock | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Series B Preferred Stock | - | 0 | 0 | 0 | -0 | 0 | 7 | - | - | - | - | - | |||||
Assets | |||||||||||||||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | - | - | 10 | 10 | 10 | 10 | 10 | 10 | - | |||||
Preferred Stock Shares Issued | - | - | - | - | - | 2 | - | - | - | - | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 100 | 2,000 | 100 | 100 | 100 | 100 | 100 | |||||
Common Stock Shares Issued | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Shares Outstanding | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.88% | -17.11% | -51.75% | - | - | - | - | - | - | - | - | - |
| 2025 | 100.00% | 130.00% | 34.54% | -30.91% | -19.09% | -15.15% | 0.46% | -72.02% | -88.03% | -10.67% | -10.67% | -25.30% |
| 2024 | -14.78% | -37.58% | -40.51% | -35.55% | -17.19% | 144.14% | -1.67% | 0.00% | -41.67% | -38.33% | -98.00% | -90.00% |
| 2023 | - | - | - | - | - | - | -12.53% | -26.58% | -49.11% | -21.58% | -46.84% | -66.63% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.60 | 0.90 | 1.03 | 2.03 | 2.81 | 3.07 | 0.21 | 0.29 | 0.38 | 0.53 | 0.74 | 0.71 | |||||
| Quick Ratio | 0.60 | 0.90 | 1.03 | 2.03 | 2.81 | 3.07 | 0.21 | 0.29 | 0.38 | 0.53 | 0.74 | 0.71 | |||||
| Working Capital | -6.34M | -2.10M | 359.00K | 4.03M | 5.71M | 6.63M | -5.62M | -4.30M | -3.83M | -2.83M | -2.00M | -1.96M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.50 | 0.52 | 1.29 | 0.59 | 0.43 | 0.37 | -1.38 | -3.62 | -10.32 | -3.02 | -5.93 | 1.36 | |||||
| Interest Coverage TTM | -42.56 | -33.19 | -16.62 | -4.36 | -3.48 | -3.21 | -3.92 | -8.46 | -5.98 | -5.88 | -7.95 | -22.78 | |||||
| Debt Ratio | 0.33 | 0.34 | 0.56 | 0.37 | 0.30 | 0.27 | 3.61 | 1.38 | 1.11 | 1.07 | 1.20 | 0.58 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.58 | 0.44 | 1.12 | 1.39 | 1.15 | 1.21 | 2.65 | 1.72 | 1.99 | 2.14 | 3.30 | 1.90 | |||||
| Days Sales Outstanding TTM | 57.20 | 93.55 | 41.78 | 57.13 | 59.48 | 64.69 | 73.42 | 17.78 | 53.93 | 50.53 | 52.00 | 32.69 | |||||
| Receivables Turnover TTM | 6.38 | 3.90 | 8.74 | 6.39 | 6.14 | 5.64 | 4.97 | 20.53 | 6.77 | 7.22 | 7.02 | 11.16 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -6.07 | -15.01 | -153.15 | -85.18 | -145.02 | -8,811.84 | -16,909.35 | -16,577.85 | -19,615.12 | -97.71 | -124.46 | -232.50 | |||||
| Free Cash Flow Per Share TTM | -5.33 | -19.42 | -270.62 | -66.69 | -70.00 | -9,996.97 | -3,062.32 | 852.58 | -1,110.61 | -8.20 | -31.05 | -108.37 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 21.53% | 19.73% | 13.61% | 31.35% | 15.18% | 19.53% | 24.71% | 45.55% | 23.48% | 22.56% | 20.41% | 18.86% | |||||
| Operating Profit Margin TTM | -57.35% | -59.94% | -70.47% | -45.14% | -37.23% | -39.29% | -40.62% | -33.96% | -27.28% | -22.56% | -23.18% | -45.40% | |||||
| Net Profit Margin TTM | -66.29% | -69.72% | -68.22% | -48.84% | -47.74% | -51.43% | -51.03% | -38.03% | -31.89% | -26.46% | -26.16% | -44.37% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 116.41% | 77.50% | 18.77% | -21.88% | -45.90% | -58.90% | -64.77% | -55.75% | -47.29% | -38.49% | -27.64% | -39.41% | |||||
| Net Income Growth (1Y) | 200.53% | 140.64% | 58.75% | 0.33% | -19.02% | -20.12% | -31.28% | -62.07% | -58.87% | -53.47% | -39.50% | 90.66% | |||||
| EPS Growth (1Y) | -95.82% | -99.83% | -99.09% | -99.49% | -99.26% | 8,918.20% | 13,486.58% | 7,030.20% | 8,131.00% | -56.42% | -46.46% | 1,505.47% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.30 | -0.18 | -0.25 | -1.85 | -2.88 | -0.51 | -0.87 | -0.44 | -0.39 | -284.39 | -329.52 | -244.82 | |||||
| P/B TTM | 0.10 | 0.05 | 0.24 | 1.34 | 1.60 | 0.34 | -1.02 | -1.53 | -4.26 | -847.00 | -2,057.64 | 663.59 | |||||
| P/S TTM | 0.20 | 0.12 | 0.17 | 0.90 | 1.38 | 0.26 | 0.44 | 0.17 | 0.13 | 75.25 | 86.20 | 108.63 | |||||
| Market Cap | 5.08M | 2.50M | 2.35M | 11.71M | 16.34M | 2.95M | 5.20M | 2.78M | 2.75M | 2.07B | 2.86B | 4.07B | |||||
| Enterprise Value | 15.00M | 7.91M | 5.46M | 11.61M | 13.53M | -3.10M | 7.83M | 3.84M | 4.45M | 2.07B | 2.87B | 4.07B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -14.96M | -18.07M | -16.74M | -4.95M | -2.73M | -6.59M | -1.08M | 324.00K | -396.00K | -610.00K | -2.17M | -7.74M | |||||
| Net Debt | 9.92M | 5.40M | 3.11M | -99.00K | -2.81M | -6.05M | 2.63M | 1.05M | 1.70M | 2.38M | 3.13M | 3.40M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Healthcare Triangle, Inc. (HCTI) — SEC Financial Statements & Analysis
Healthcare Triangle, Inc. (HCTI) is a services-computer integrated systems design company, incorporated in DE. Healthcare Triangle, Inc. trades on Nasdaq as: HCTI. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Healthcare Triangle, Inc. reported a 116.41% year-over-year revenue growth, a Gross Profit Margin of 21.53% (TTM), a Debt-to-Equity ratio of 0.50x, a Price-to-Sales (P/S) ratio of 0.20x (TTM), a Price-to-Book (P/B) ratio of 0.10x (TTM), at a market cap of $5.08M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 116.41%
- Gross Profit Margin TTM
- 21.53%
- Debt To Equity
- 0.50x
- P/S TTM
- 0.20x
- P/B TTM
- 0.10x
- Market Cap
- $5.08M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Healthcare Triangle, Inc. in?
Healthcare Triangle, Inc. (HCTI) operates in the Services-Computer Integrated Systems Design industry.
What is HCTI's market cap?
Healthcare Triangle, Inc. (HCTI) has a market capitalization of $5.08M as of 2026-06-30.
What exchange does HCTI trade on?
Healthcare Triangle, Inc. (HCTI) trades on the Nasdaq.
Where is Healthcare Triangle, Inc. incorporated?
Healthcare Triangle, Inc. is incorporated in DE.